Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001046 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections
Pregnancy
HIV Seronegativity

Interventions

BIOLOGICAL: MF59
BIOLOGICAL: rgp120/HIV-1 SF-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)